In Breast Cancer Patients, What Accounts for Racial Disparities in Pathologic Complete Response? - Early Breast Cancer

Non-Hispanic Black patients with breast cancer undergoing neoadjuvant chemotherapy have a lower likelihood of experiencing pathologic complete response compared with non-Hispanic White patients. A new study examines several potential reasons why.

Racial disparities in breast cancer may have genetic factor - STAT

Disparities in Clinical Research and Cancer Treatment

Neoadjuvant Chemotherapy for Breast Cancer: Racial/Ethnic

Racial disparities in survival outcomes among breast cancer

Vital Signs: Racial Disparities in Breast Cancer Severity — United

IJMS, Free Full-Text

Efficacy of durvalumab for early-stage triple-negative breast

Addressing Disparities in the Care of Patients with Triple

Vital Signs: Racial Disparities in Breast Cancer Severity — United

Study Finds Race-Based Disparities in Pathologic Complete Response

Reducing Racial Disparities in Early Cancer Diagnosis With Blood

Inflammatory Breast Cancer Characteristics

Machine learning prediction of pathological complete response and

Disparities in Clinical Research and Cancer Treatment

The impact of race and age on response to neoadjuvant therapy and